Azithromycin Linked to Cardiovascular Death — Not A Placebo After All
Paul Sax, M.D. • May 16, 2012
I’ve commented before about azithromycin, that remarkable antibiotic that clinicians seem to prescribe for, gosh, you-name-it. But a paper just published in the New England Journal of Medicine links use of azithromycin to an increased risk of cardiovascular death, a reminder that “azithro” is in fact a drug — and that all drugs have side... Keep Reading...
More Posts...
- Advisory Meeting Today on Tenofovir/FTC for PrEP, and a Proposed “Niche” for its Use
- Difficulties and Differences on C difficile
- Do We Really Need Primary Prophylaxis for OIs Anymore?





